சவாரி ஹேன்சன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Scandion Oncology engages former ASCO executive as clinical advisor Scandion Oncology is pleased to announce that we have appointed Dr. Richard L. Schilsky, a seasoned and highly profiled international leader as a member of our clinical advisory board (CAB). Dr. Schilsky is the former CMO and Executive Vice President of the American Society of Clinical Oncology (ASCO) and a long-time faculty member of the University of Chicago. Scandion Oncology A/S Publicerad: 21 april 2021, 11:30 Copenhagen, April 21, 2021. Scandion Oncology, The Cancer Drug Resistance Company, is pleased to announce that Richard L. Schilsky, MD, FACP, FSCT, FASCO has accepted to join the clinical advisory board of Scandion Oncology.

Richard schilskyPeter michael vestlevRichardl schilskyEuropean organization for researchDrug administrationSciences divisionCancer drug resistance companyDean for clinical researchUdall foundationOncologic drugs advisory committeeUniversity of chicagoUniversity of chicago cancer research centerFriends of cancer researchDepartment of medicineTranslational research committeeScandion oncology